Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Annelieke C. Kruithof"'
Autor:
Manon L. M. Prins, Geert V. T. Roozen, Cilia. R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia. A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia. C. de Kroon, Shohreh Azimi, Mariet C. W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H. M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H. E. Roukens
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Fractional dosing can be a cost-effective vaccination strategy to accelerate individual and herd immunity in a pandemic. We assessed the immunogenicity and safety of primary intradermal (ID) vaccination, with a 1/5th dose compared with the s
Externí odkaz:
https://doaj.org/article/8c7cdcae1f5e4775b3bf74058e2d2a84
Autor:
Jonas M. den Heijer, Annelieke C. Kruithof, Matthijs Moerland, Mike Walker, Lindsay Dudgeon, Craig Justman, Imelda Solomini, Leslie Splitalny, Nancy Leymarie, Kshitij Khatri, Valerie C. Cullen, Dana C. Hilt, Geert Jan Groeneveld, Peter Lansbury
Publikováno v:
Movement Disorders.
Autor:
Geert V.T. Roozen, Margaretha L.M. Prins, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Annelieke C. Kruithof, Mariet C.W. Feltkamp, Marjan Kuijer, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens
Publikováno v:
Annals of Internal Medicine. AMER COLL PHYSICIANS
Annals of Internal Medicine
Annals of Internal Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71344eb25670de5c89ef3026b6ac2de6
https://hdl.handle.net/1887/3514839
https://hdl.handle.net/1887/3514839
Autor:
Adam F. Cohen, Geert Jan Groeneveld, Jeroen van Smeden, Jules A. A. C. Heuberger, Hemme J. Hijma, Jonas M. den Heijer, Jacobus Burggraaf, Annelieke C. Kruithof
Publikováno v:
British Journal of Clinical Pharmacology. 87:4552-4559
Autor:
Ria H. Laterveer, Annelieke C. Kruithof, Cornelis Kluft, Matthijs Moerland, Pieter-Jan de Kam, Jacobus Burggraaf
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 59:89-98
Objective To explore the mode of action (MoA) by which sugammadex interferes with coagulation. Materials and methods The effect of sugammadex on various steps in the coagulation cascade including thrombin generation, factor Xa activity, and factor Xa
Autor:
Rajinder Kumar, Rajesh Gandhi, Ingrid M C Kamerling, Marieke L. de Kam, Anirudh Gautam, Bijay Kumar Padhi, Jasper Stevens, Kulkarni Swati, Rajeev Singh Raghuvanshi, Shanavas Alikunju, Jacobus Burggraaf, Annelieke C. Kruithof
Publikováno v:
Clinical pharmacology in drug development, 8(8), 1042-1052
DRL-17822 is a novel selective cholesteryl ester transfer protein inhibitor that showed an increased exposure, including an increase of >20-fold of maximum concentration and area under the plasma concentration-time curve from time zero to the time of
Autor:
Anna H. Roukens, Annelieke C. Kruithof, Geert V.T. Roozen, Manon Prins, Jacqueline J. Janse, Mariet C.W. Feltkamp, Marjan Kuijer, Rob van Binnendijk, Leo G. Visser, Gerco den, Frits R Roosendaal, Vincent Kuiper, Corine Prins, Meta Roestenberg
BackgroundThere is an urgent need for fair and equitable access to safe and effective vaccines to end the COVID-19 pandemic. Shortages in reagents and vaccines are a major challenge, as well as limited knowledge on dose response relationship with mRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca524875b17cfefc540a5fe9ba622277
https://doi.org/10.1101/2021.07.27.21261116
https://doi.org/10.1101/2021.07.27.21261116
Autor:
Jonas M. den Heijer, Hendrika W. Grievink, Eva Thijssen, Guido van Amerongen, Marieke L. de Kam, Dana C. Hilt, Annelieke C. Kruithof, Matthijs Moerland, Geert Jan Groeneveld, Renato T. Skerlj, Valerie Christina Cullen, Mike Walker, Kees Been, Peter T. Lansbury, Craig J. Justman, Lindsay Dudgeon
Publikováno v:
British Journal of Clinical Pharmacology, 87(9), 3561-3573. WILEY
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology
Aims A mutation in the GBA1 gene is the most common genetic risk factor for developing Parkinson's disease. GBA1 encodes the lysosomal enzyme glucosylceramidase beta (glucocerebrosidase, GCase) and mutations decrease enzyme activity. LTI-291 is an al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e6d582dc76ec1718a1a83f9b5bdc35
http://hdl.handle.net/1887/3278255
http://hdl.handle.net/1887/3278255
Autor:
Corine Prins, Meta Roestenberg, Jacqueline J. Janse, Anna H.E. Roukens, Vincent P. Kuiper, Mariet C.W. Feltkamp, Robert S. van Binnendijk, Margaretha L.M. Prins, Marjan Kuijer, Gerco den Hartog, Frits R. Roosendaal, Geert V.T. Roozen, Annelieke C. Kruithof, Leo G. Visser
Publikováno v:
SSRN Electronic Journal.
Background: There is an urgent need for fair and equitable access to safe and effective vaccines to end the COVID-19 pandemic. Shortages in reagents and vaccines are a major challenge, as well as limited knowledge on dose response relationship with m
Autor:
Cornelis Kluft, Annelieke C. Kruithof, Geertruida H Laterveer, Jacobus Burggraaf, Matthijs Moerland, Pieter-Jan de Kam
Publikováno v:
International journal of clinical pharmacology and therapeutics. 58(7)
Objective To investigate in vitro the effect of sugammadex on activated partial thromboplastin time (APTT) and prothrombin time (PT) prolongations with various anticoagulants as well as the neutralizing effect of rocuronium and vecuronium on sugammad